NitroMed terminates agreement to sell assets of BiDil drug business to JHP Pharmaceuticals - MarketLine Financial Deals

NitroMed terminates agreement to sell assets of BiDil drug business to JHP Pharmaceuticals

NitroMed terminates agreement to sell assets of BiDil drug business to JHP Pharmaceuticals - MarketLine Financial Deals
NitroMed terminates agreement to sell assets of BiDil drug business to JHP Pharmaceuticals
Published Jan 27, 2009
2 pages — Published Jan 27, 2009
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Nitromed, Inc., a pharmaceutical manufacturer focused on cardiovascular diseases, has terminated its agreement to sell the assets related to BiDil drug business to JHP Pharmaceuticals, LLC, a specialty pharmaceutical company.

  
Source:
Document ID
MA00312_081023
Country
Ticker
NTMD=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "NitroMed terminates agreement to sell assets of BiDil drug business to JHP Pharmaceuticals" Jan 27, 2009. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/NitroMed-terminates-agreement-to-sell-assets-of-BiDil-drug-business-to-JHP-Pharmaceuticals-2052-252>
  
APA:
MarketLine Financial Deals. (2009). NitroMed terminates agreement to sell assets of BiDil drug business to JHP Pharmaceuticals Jan 27, 2009. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/NitroMed-terminates-agreement-to-sell-assets-of-BiDil-drug-business-to-JHP-Pharmaceuticals-2052-252>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.